- Home
- SPRY vs DMLP Comparison
SPRY vs DMLP Comparison
Compare SPRY & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- DMLP
- Stock Information
- Founded
- SPRY 2015
- DMLP 2003
- Country
- SPRY United States
- DMLP United States
- Employees
- SPRY N/A
- DMLP N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- DMLP Oil & Gas Production
- Sector
- SPRY Health Care
- DMLP Energy
- Exchange
- SPRY Nasdaq
- DMLP Nasdaq
- Market Cap
- SPRY 1.1B
- DMLP 1.1B
- IPO Year
- SPRY N/A
- DMLP N/A
- Fundamental
- Price
- SPRY $9.59
- DMLP $21.30
- Analyst Decision
- SPRY Strong Buy
- DMLP
- Analyst Count
- SPRY 4
- DMLP 0
- Target Price
- SPRY $31.25
- DMLP N/A
- AVG Volume (30 Days)
- SPRY 2.5M
- DMLP 222.4K
- Earning Date
- SPRY 11-10-2025
- DMLP 11-06-2025
- Dividend Yield
- SPRY N/A
- DMLP 15.14%
- EPS Growth
- SPRY N/A
- DMLP N/A
- EPS
- SPRY N/A
- DMLP 1.13
- Revenue
- SPRY $142,772,000.00
- DMLP $143,803,000.00
- Revenue This Year
- SPRY N/A
- DMLP N/A
- Revenue Next Year
- SPRY $193.13
- DMLP N/A
- P/E Ratio
- SPRY N/A
- DMLP $18.89
- Revenue Growth
- SPRY 5459.66
- DMLP N/A
- 52 Week Low
- SPRY $6.66
- DMLP $21.18
- 52 Week High
- SPRY $18.90
- DMLP $34.88
- Technical
- Relative Strength Index (RSI)
- SPRY 57.78
- DMLP 25.00
- Support Level
- SPRY $6.66
- DMLP $21.18
- Resistance Level
- SPRY $7.40
- DMLP $23.64
- Average True Range (ATR)
- SPRY 0.80
- DMLP 0.73
- MACD
- SPRY 0.21
- DMLP -0.15
- Stochastic Oscillator
- SPRY 78.83
- DMLP 4.69
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.